Position in PFE
as of Jun 30, 2026
· filed Jul 31, 2026
Position Value
$22,394
-$2,316 QoQ
Shares Held
930
+5.7% QoQ
Ownership
0.000%
of shares outstanding
% of Portfolio
0.15%
of 13F equity value
Holder Rank
#2,710
of 2,834 holders
Holding Since
Dec 2024
7 quarters on record
Voting authority
Sole 0%
Shared 0%
None 100%
Common Shares in PFE Over Time
Shares Held
Position Value (USD)
Position in Drug Manufacturers - General
Healthcare · as of Jun 30, 2026Navigoe, LLC holds $1,093,900 across 13 Drug Manufacturers - General names. PFE ranks #6 (2.0% of the industry book) .
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | AMGN |
Amgen Inc
|
2,027 | $734,017 | |
| 2 | LLY |
ELI LILLY & Co
|
113 | $135,535 | |
| 3 | ABBV |
AbbVie Inc.
|
518 | $130,349 | |
| 4 | BMY |
Bristol Myers Squibb Co
|
445 | $25,640 | |
| 5 | JNJ |
Johnson & Johnson
|
91 | $23,111 | |
| 6 | PFE |
Pfizer Inc
This page
|
930 | $22,394 | |
| 7 | MRK |
Merck & Co., Inc.
|
114 | $14,649 | |
| 8 | NVS |
Novartis AG
|
23 | $3,604 |
All Filings in PFE
Export CSV
7 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-06-30 | $22,394 | 930 | Shares | Sole | 2026-07-31 | |
| 2026-03-31 | $24,710 | 880 | Shares | Sole | 2026-05-01 | |
| 2025-12-31 | $21,912 | 880 | Shares | Sole | 2026-02-03 | |
| 2025-09-30 | $22,422 | 880 | Shares | Sole | 2025-10-10 | |
| 2025-06-30 | $21,331 | 880 | Shares | Sole | 2025-08-14 | |
| 2025-03-31 | $22,299 | 880 | Shares | Sole | 2025-05-09 | |
| 2024-12-31 | $23,346 | 880 | Shares | Sole | 2025-02-14 | |
| No filing history on record for this holder in this stock. | ||||||